Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation.

Source:http://linkedlifedata.com/resource/pubmed/id/18798073

Download in:

View as

General Info

PMID
18798073